Regulus Therapeutics
RGLS
#6949
Rank
HK$4.39 B
Marketcap
HK$63.50
Share price
0.00%
Change (1 day)
436.85%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: HK$4.39 Billion

As of December 2025 Regulus Therapeutics has a market cap of HK$4.39 Billion. This makes Regulus Therapeutics the world's 6949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$4.39 B461.39%
2024HK$0.78 B287.36%
2023HK$0.20 B12.15%
2022HK$0.18 B-49.72%
2021HK$0.35 B-46.05%
2020HK$0.66 B356.18%
2019HK$0.14 B126.72%
2018HK$64.26 M-92.39%
2017HK$0.84 B-8.52%
2016HK$0.92 B-74.06%
2015HK$3.55 B-41.54%
2014HK$6.08 B154.3%
2013HK$2.39 B36.85%
2012HK$1.74 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
HK$760.42 B 17,196.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$940.80 B 21,299.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$206.97 B 4,607.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.175 T 49,392.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
HK$470.98 B 10,613.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$1.29 B-70.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$826.14 B 18,691.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.17 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA